NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It
In Brief: NCI Planning 50th Anniversary In 1987, Seeks Information On Alumni For Observance In May
Public Should Be Warned About Smokeless tobacco Risks, Panel Says
Smokeless Tobacco Warning Bill May Go To House Floor
NCI To Recompete Smokeless Tobaccos RFA as PA
ACOS Survey To Assess Tumor Boards’ Impact On Patient Care
Hospice Assn. Meeting Planned for April
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - With five-year cancer survival at an all-time high, does this mean people are living longer?
- Blood Cancer United: A new name at the right moment
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer









